Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of John Butler
Person

John Butler

Overview

Edit Overview Section
CB Rank (Person) 448,990
John Butler is the President and CEO at Akebia Therapeutics.

Jobs

Edit Jobs Section
Number of Current Jobs 1
Number of Past Jobs 2
John Butler is the President & CEO at Akebia Therapeutics. Additionally, John Butler has had 2 past jobs including Chairman of the Board of Trustees at American Kidney Fund.
Organization Name  
Title At Company  
Start Date  
End Date  
American Kidney Fund Logo
American Kidney Fund
Chairman of the Board of TrusteesMay 2008Mar 2018
Genzyme Logo
Genzyme
President19972011

Related Hubs

Edit Related Hubs Section
Hub Name  
CB Rank (Hub)  
Therapeutics Public Companies With Fewer Than 1000 Employees Logo
Therapeutics Public Companies With Fewer Than 1000 Employees
18,321
New England Public Companies With More Than $1M in Revenue Logo
New England Public Companies With More Than $1M in Revenue
33,023
Northeastern US Biotechnology Public Companies Logo
Northeastern US Biotechnology Public Companies
99,991
New England Public Companies Logo
New England Public Companies
25,216
Cambridge Companies With More Than $10M in Revenue Logo
Cambridge Companies With More Than $10M in Revenue
58,015
Massachusetts Therapeutics Companies Logo
Massachusetts Therapeutics Companies
40,764
Cambridge Companies that Exited Logo
Cambridge Companies that Exited
35,844
Novo Holdings Portfolio Companies Logo
Novo Holdings Portfolio Companies
75,963
Northeastern US Therapeutics Companies Logo
Northeastern US Therapeutics Companies
18,235
Therapeutics Companies With More Than $50M in Revenue Logo
Therapeutics Companies With More Than $50M in Revenue
28,589

Education

Edit Education Section
John Butler studied at Manhattan College and  Baruch College.

Recent News and Activity

Edit Recent News and Activity Section
Number of News Articles 5
News•May 5, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 4, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 15, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 29, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 29, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|